Posted by AGORACOM-JC
at 4:32 AM on Monday, March 21st, 2022
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing the high value-added silicon products sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now. CEO Bernard Tourillon goes “Beyond the Deck” to provide shareholders a comprehensive company update.
Some topics we discuss:
THIRD PARTY VALIDATION FROM LEADING GLOBAL COMPANIES
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
And $HPQ timing couldn’t be better as the price for 1 metric ton of Silicon, as of the end of 2021, reached US $10,000 compared to just US $2,500 a year ago.
CEO Bernard Tourillon commented:“Since 2015, HPQ PUREVAP T M QRR has been at the forefront of disrupting Silicon manufacturing, an industry that still relies on a traditional process to make silicon first develop in 1899. The U.S. patent issuance on our novel new approach to making silicon, combined with the end of Q1 start of the GEN3 PUREVAP TM QRR pilot plant , have culminated at an opportune time, as demand for high purity silicon from the battery and high-performance material companies continues to rise just as bottlenecks, we had foreseen are now occurring in the silicon supply chain. With ESG principles playing an active role in materials sourcing, the world is more aware of the difficulties of securing the ESG compliant Silicon needed to meet its renewable energy goals. The reality of chronic underinvestment in new technologies combined with the offshoring of Silicon production capacity, has created a massive opportunity for HPQ and its PUREVAP TM QRR patented process, as we are the only company to bring to market a new process for making Silicon that is perfectly suited to the new demands and realities of the Silicon market.”
Sit back, relax and watch this powerful presentation.
Posted by AGORACOM-JC
at 4:16 PM on Wednesday, March 9th, 2022
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing the high value-added silicon products sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now.
THIRD PARTY VALIDATION FROM LEADING GLOBAL COMPANIES
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
And $HPQ timing couldn’t be better as the price for 1 metric ton of Silicon, as of the end of December, reached US $10,000 compared to just US $2,500 a year ago.
CEO Bernard Tourillon commented:“Since 2015, HPQ PUREVAP T M QRR has been at the forefront of disrupting Silicon manufacturing, an industry that still relies on a traditional process to make silicon first develop in 1899. The U.S. patent issuance on our novel new approach to making silicon, combined with the end of Q1 start of the GEN3 PUREVAP TM QRR pilot plant , have culminated at an opportune time, as demand for high purity silicon from the battery and high-performance material companies continues to rise just as bottlenecks, we had foreseen are now occurring in the silicon supply chain. With ESG principles playing an active role in materials sourcing, the world is more aware of the difficulties of securing the ESG compliant Silicon needed to meet its renewable energy goals. The reality of chronic underinvestment in new technologies combined with the offshoring of Silicon production capacity, has created a massive opportunity for HPQ and its PUREVAP TM QRR patented process, as we are the only company to bring to market a new process for making Silicon that is perfectly suited to the new demands and realities of the Silicon market.”
Sit back and watch this power interview with HPQ CEO Bernard Tourillon.
Posted by AGORACOM-JC
at 2:54 PM on Friday, February 25th, 2022
AGORACOM Twitter Engagement Metrics Beat Benchmarks By 230%*
AGORACOM Cashless Marketing Program Is 100% Compliant With TSXV, CSE and NEO
Last week we were proud to announce another AGORACOM major milestone when we surpassed 710 Million page views (81% AGORACOM / 19% Twitter) from 8.8 Million investors that visited 63.3 Million times over the last 13 years.
These milestones are significant because they continue to demonstrate that AGORACOM is the primary home for serious small cap investors that want to discover their next great small-cap investment.
Today we are proud to announce 2 more major milestones for the 2021 year:
We launched “Twitter Mini Clips” in the summer and racked up 160,000 + minutes
Our engagement rate is 230% than the best benchmarks of all Twitter campaigns
MAKE SURE YOU FOLLOW US AND SHARE THE GREAT CONTENT WE CREATE FOR YOU!
If you haven’t seen the incredible year-round content we create for you, please make sure to ask your Account Executive to see it. Then make sure your social media team is following us so that you can use and share our great content any way you like!
SMALL CAP INVESTORS LOVE AGORACOM VIDEO CONTENT
If a picture is worth 1,000 words, a great video is worth thousands of happy shareholders!
AGORACOM videos receive the highest engagement rates and shareholder testimonials in the industry because we take the time to produce both great content and high production value that viewers truly appreciate. Click on the image below to see some of our recent great testimonials … or use this link!
MAKE SURE YOU FOLLOW US AND SHARE THE GREAT VIDEOS WE CREATE FOR YOU!
If you haven’t seen the incredible LONG & SHORT video content we create for you, please make sure to ask your Account Executive to see it. Then make sure your social media team is following us so that you can use and share our great video content with your networks!
HOW DOES AGORACOM CREATE INDUSTRY-LEADING ENGAGEMENT?
The fight for investor attention is stronger than ever. Within the small cap industry investors are inundated with mountains of information from email to social media.
Moreover, the small cap industry is now facing stiff new competition for investor attention from the fast-rising Web3 world of Cryptocurrencies, NFTs and Blockchains.
It’s enough to make both investors and issuers dizzy.
AGORACOM overcomes this challenge and wins the battle for investor attention by going the extra mile to create great content. While most firms communicate via “lazy linking” AGORACOM Founder and former lawyer George Tsiolis relies on his communications training to make sure the account management team delivers the following winning variety of content:
FORM – Blogs, Posts, Tweets, Comments, Videos, Audio, Graphics and GIFs
LENGTH – Ultra Long, Long, Medium, Short and Micro
PLATFORMS – YouTube, Twitter, LinkedIn, Facebook, Instagram, Spotify, Search, TikToK (yeah but no dancing!) … and of course our very own AGORACOM.com
Click on the image below to watch a concise but powerful 75-second video to get a great glimpse of our industry-leading content machine … or just click on this link:
This unmatched variety in the form, length and distribution of our content removes all the noise for investors while providing clients with a complete digital marketing solution.
ZERO $ … AGORACOM CASHLESS AND 100% COMPLIANT PROGRAM
As a small cap company, your cash is invaluable and shouldn’t be used for anything other than operations and growth. You’ll be happy to know The AGORACOM Cashless, Shares For Services Program is fully compliant with the TSX Venture, CSE and NEO Exchanges. As such, it is considered the friendliest comp structure in the entire industry and can be summarized as follows:
Shares are issued in 5 X $20,000 installments over the twelve month term.
Start Date
End Of Q1
End Of Q2
End Of Q3
End Of Q4
The number of shares issued is determined by the share price at each date. As the issuer share price goes higher, the number of shares issued to AGORACOM decreases.
Each issuance comes with customary 4-month hold periods. As such, AGORACOM is a shareholder for at least 16 months (Q4 + 4 Months)
Structure means AGORACOM becomes a long-term shareholder that is completely aligned with the Company
Posted by AGORACOM-JC
at 8:28 AM on Friday, February 18th, 2022
*AGORACOM Engagement Metrics Beat Benchmarks By 364% *AGORACOM Cashless Marketing Program Is 100% Compliant With TSXV, CSE and NEO
We are very proud to announce AGORACOM achieved another major milestone for the period December 31, 2021, when we surpassed 710 Million page views (81% AGORACOM / 19% Twitter) from 8.8 Million investors that visited 63.3 Million timesover the last 13 years.
These milestones are significant because they continue to demonstrate that AGORACOM is the primary home for serious small cap investors that want to discover their next great small cap investment. We owe much of this success to the following 2 major factors:
QUALITY OVER QUANTITY – Unlike small cap sites and major platforms that struggle with spam, profanity and overall nonsense, AGORACOM has implemented and strictly enforces it’s 6 Rules Of Use that create robust but civilized debate and discussion.
FOCUS. NOTHING BUT SMALL CAP – Despite the fact we are all in the finance industry, we don’t talk about macro finance, large cap or general economic news. Investors come to AGORACOM for just one thing – great small cap content .. and they don’t hesitate to show their love for us. AGORACOM ENGAGEMENT SHATTERS FINANCE BENCHMARKS BY 364%
AGORACOM small cap investors don’t just flip through pages, they invest a significant amount of time reading, studying and researching our small cap stocks like yours. …. And they do it far more than everywhere else. Here are the numbers:
PAGES READ PER VISIT > 364% HIGHER THAN INDUSTRY STANDARD
In a recent survey of 357 finance sites, LittleData determined the average number of pages read per visit was 2.0. The average number of pages read on AGORACOM are 9.28, which is 364% higher than the benchmark.
Moreover, when it came to the best 10% of all finance sites, AGORACOM has them beat hands down as well, with LittleData determining anything greater than 4.1 pages per visit represents the best 10% of all Finance sites. With AGORACOM registering 9.67 pages per visit for a 136% beat, it is fair to say AGORACOM is in elite status for engagement.
TIME SPENT PER VISIT > 161% HIGHER THAN INDUSTRY STANDARD
The average visitor to AGORACOM stays on the site for an average of 8 mins 23 secs. To put this into perspective, The Contentsquare Digital Experience Benchmark Report determined an average visit to financial services sites of 3 mins 13 secs, placing AGORACOM engagement 161% higher. Here are some comparables against some of the world’s biggest finance sites:
AGORACOM 8 mins 23 secs Wall Street Journal 3 mins 18 secs Marketwatch 5 mins 47 secs Motley Fool 1 mins 50 secs FOX Business 3 mins 39 secs Investing.com 5 mins 53 secs
HOW DOES AGORACOM CREATE INDUSTRY LEADING ENGAGEMENT?
The fight for investor attention is stronger than ever. Within the small cap industry investors are inundated with mountains of information from email to social media.
Moreover, the small cap industry is now facing stiff new competition for investor attention from the fast rising Web3 world of Cryptocurrencies, NFTs and Blockchains.
It’s enough to make both investors and issuers dizzy.
AGORACOM overcomes this challenge and wins the battle for investor attention by going the extra mile to create great content. While most firms communicate via “lazy linking” AGORACOM Founder and former lawyer George Tsiolis relies on his communications training to make sure the account management team delivers the following winning variety of content:
FORM – Blogs, Posts, Tweets, Comments, Videos, Audio, Graphics and GIFs
LENGTH – Ultra Long, Long, Medium, Short and Micro
PLATFORMS – YouTube, Twitter, LinkedIn, Facebook, Instagram, Spotify, Search, TikToK (yeah but no dancing!) … and of course our very own AGORACOM.com
Watch this concise but powerful 60-second video to get a great glimpse of our industry leading content machine. This unmatched variety in the form, length and distribution of our content removes all the noise for investors while providing clients with a complete digital marketing solution.
ZERO $ … AGORACOM CASHLESS AND 100% COMPLIANT PROGRAM
As a small cap company, your cash is invaluable and shouldn’t be used for anything other than operations and growth. You’ll be happy to know The AGORACOM Cashless, Shares For Services Program is fully compliant with the TSX Venture, CSE and NEO Exchanges. As such, it is considered the friendliest comp structure in the entire industry and can be summarized as follows:
Shares are issued in 5 X $20,000 installments over the twelve month term.
-Start Date -End Of Q1 -End Of Q2 -End Of Q3 -End Of Q4
-The number of shares issued is determined by the share price at each date. As the issuer share price goes higher, the number of shares issued to AGORACOM decreases.
-Each issuance comes with customary 4-month hold periods. As such, AGORACOM is a shareholder for at least 16 months (Q4 + 4 Months)
-Structure means AGORACOM becomes a long-term shareholder that is completely aligned with the Company
-$0 Cash + the full firepower of AGORACOM
CONCLUSION
Massive audience + industry leading engagement + industry leading content + $0 cash, 100% compliant shares for services
Posted by AGORACOM-JC
at 5:25 PM on Thursday, January 6th, 2022
The global e-commerce market surpassed $9 TRILLION in 2019 … and is scheduled to grow by a CAGR of 14% into 2027 … But mega brands control almost 70% of the US market alone and are using their strength to win even more market … making it harder for SMBs to compete in this massive market.
Logiq …. a public company for just 4 months…. is an award-winning e-commerce and fintech solutions company that is addressing that problem by helping drive e-commerce for SMBs around the world … with revenues of $37.9M in 2020 …. from 2 divisions:
AppLogiq (Agreement finalized to Transfer AppLogiq Assets into Publicly Traded Subsidiary) – In Southeast Asia AL offers a mobile application development platform as-a-service which enables hundreds of thousands of SMBs to create mobile apps with little technical expertise or know-how … Offered across Southeast Asia, Europe and U.S. in 14 languages .. …. also offers a mobile fintech payment platform (PayLogiQ) and a hyper-local food delivery service (GoLogiq)
DataLogiq – provides a data-driven, end-to-end e-commerce marketing solution that integrates AI to help SMBs in need of online marketing solutions.
Financial Highlights:
2020 revenue of $37.9 million … 31% CAGR since 2016
Revenue H1-21 $16.4 million
Revenue Q2-21 $8.3 million …
margin of 29.5%
up 16.4 percentage points from the year-ago quarter.
Revenue Q3-21 $7.8 million
margin for DataLogiq: improved from 18.9% to 28.2%.
margin for AppLogiq: improved from 12.1% to 31.7%.
Q4-21 Revenue Estimate: $12.3 million, up 87% vs Q4-20
Gross margin expected to 34.0% vs 29.5% in the previous Q / 21.1% in Q4-20
Brent Suen, president of Logiq commented,
“Our improving revenue performance throughout 2021 demonstrates our team’s commitment to driving a transformation of our business overall and providing visibility on future profitability. As we refocused our efforts on higher quality, more profitable revenue streams and adjusted to the changing market dynamics, we also drove strong gross margin improvement every quarter of 2021. In fact, our gross margin more than doubled in Q4 2021 compared to the full year of 2020.”
Suen continued,
“We believe this strong progress across the board is keeping us on the path to profitability for both of our business segments,” continued Suen. “It also advances our plans to separate our DataLogiq and AppLogiq businesses into two independent publicly traded companies as another way to further unlock shareholder value.”
Now sit back, relax and watch this powerful interview.
Posted by AGORACOM-JC
at 5:48 PM on Wednesday, December 8th, 2021
HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high-value specialty silicon products needed for the coming RER along with 2 world-renowned technology partners.
high purity silicon metal
spherical silicon nanopowders and nanowires
porous silicon (Si) wafers and porous silicon (Si) powders
HPQ NANO Receives First Order for Spherical Nano Silicon Material from Major Automobile Manufacturer
NDA with at least 2 battery players
Pyrogenesis Canada (a global leader in plasma torch technologies) = 2 reactors
PUREVAP Quartz Reduction Reactors (QRR) to be Commissioned in Q4 2021
an innovative process (patent pending), which will permit the one-step transformation of quartz (SiO 2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint
PUREVAP TM Nano Silicon Reactor (NSiR ) Through its 100% owned subsidiary, HPQ NANO Silicon Powders Inc., a new proprietary process that can use different purities of silicon (Si) as feedstock, to make a wide range of nano/micro spherical powders of different sizes and nanowires.
EBH 2 first successfully tested prototype model has a clean energy production capacity starting at 1 Megawatt of power that can be produced over 7 days from 2 litres of water; sufficient energy to power a typical three bedroom suburban house.
The tests confirmed that the EBH 2 Green Hydrogen Reactors (EBH 2 GHR) uses low voltage 1 to power electrolysers that generate a H 2 + O 2 gas mixture fuels that can be used to power a generator or any kind of fuel system to produce electricity.
HPQ CEO Bernard Tourillon commented: “Corporations and Governments worldwide strongly believe that Hydrogen can play a significant part in decarbonising our economies, and they are willing to invest billions of dollars to help develop green hydrogen production. EBH2 Systems SA, with their proprietary low-cost electrolyser technology, present HPQ with one of these game changing synergetic opportunities that we simply could not overlook,” Mr. Tourillon, further stated: “We are getting even closer to the point where EBH 2 technology will be validated and when that occurs HPQ will be very well positioned to enter the hydrogen market with a system that can efficiently produce green hydrogen, on demand, which we believe will complement our green silicon materials initiatives needed to meet the demand of the up and coming renewable energy revolution.”
Sit back and watch this power interview with HPQ CEO Bernard Tourillon.
Posted by AGORACOM-JC
at 4:37 PM on Tuesday, November 30th, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing high value-added silicon products that are sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To understand the importance and the implications of this milestone, this excerpt from the press release says it all:
The US patent covers the PUREVAP™ QRR innovative process, which permits the one-step transformation of quartz (SiO 2 ) into high purity silicon metal (from 99.5% to 99.99% Si) at reduced costs, energy input, and carbon footprint. This game-changing advantage means that the PUREVAP™ QRR process not only produces a higher purity silicon material than traditional processes, but it does not require the extremely pure feedstock needed by conventional processes. In fact, the process only requires 4.5 MT of raw material to make 1 MT of Silicon, versus the 6 MT required by conventional processes, a 25% reduction which potentially allows a 20% cash cost advantage versus the lowest cost traditional Silicon producer . Furthermore, as part of our ongoing strategy of protecting and strengthening the PUREVAP™ Intellectual Property Portfolio, a second patent application, focusing on a new and novel process was filed in 2019 and is presently advancing through the process.
Bernard Tourillon, President and CEO of HPQ commented,
“HPQ has been at the forefront of Low-Cost Green Silicon innovation developments since 2015, and getting this U.S. patent approval, combined with the ongoing commissioning of the GEN3 PUREVAP™ QRR pilot plant , has occurred at an opportune time, as demand continues to rise and bottlenecks we had foreseen are now occurring in the silicon supply chain. With ESG principles playing an active role in materials sourcing, the world is more aware of the difficulty of securing the ESG compliant Silicon needed to meet its renewable energy goals. The reality of chronic underinvestment in new technologies combined with the offshoring of Silicon production capacity, has created a massive opportunity for HPQ and its PUREVAP™ QRR patented process, as we are the only company to bring to market a new process to make Silicon that is perfectly suited to the new demands and realities of the Silicon market
Watch this great interview with $HPQ CEO Bernard Tourillon.
Posted by AGORACOM-JC
at 12:18 PM on Wednesday, June 23rd, 2021
Strategic focus on developing and delivering psychedelic medicines to treat Addiction.
Strong psychedelic drug development pipeline targeting Addiction.
First mover advantage for clinics in the UK and the EU with 400m people and CAD$25TR GDP.
The leading research and clinical team in the industry focused on using psychedelics to treat Addiction.
Multiple scalable revenue streams across drug development and clinical delivery.
Toronto, Ontario–(June 23, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (“Awakn” or the “Company“) a biotechnology company with clinical operations developing, and delivering psychedelic medicines to treat Addiction, is pleased to announce it will begin trading today, June 23, 2021, on the NEO Exchange Inc. (the “NEO”) under the symbol “AWKN”.
“Listing on the NEO is an important milestone for Awakn to continue to build on our dual strategic focus of developing psychedelic drugs, therapies, and enabling technologies to treat Addiction, and delivering psychedelic treatments for Addiction in our clinics,” said Awakn CEO, Anthony Tennyson. “The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic roll out programs.”
The listing follows the successful completion of the previously announced reverse takeover of a Canadian public company, 2835517 Ontario Ltd., by Toronto-based Awakn Life Sciences Inc. The public company was subsequently renamed Awakn Life Sciences Corp. in connection with the reverse takeover and the listing on the NEO. Additionally, the Company raised gross proceeds of approximately USD$8.3 million through a brokered private placement.
Awakn engaged Canaccord Genuity Corp. and Eight Capital as co-lead agent and joint bookrunners to complete the brokered financing. In connection with the transaction, 2835517 Ontario Ltd. was de-listed from the NEX board of the TSX Venture Exchange.
A filing statement with information about Awakn prepared in accordance with the policies of the NEO is available on SEDAR at www.sedar.com.
About Awakn Life Sciences
Awakn Life Sciences is a biotechnology company with clinical operations, researching, developing, and delivering psychedelic medicine to better treat Addiction. Awakn’s team consists of world leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat Addiction. Awakn will also deliver evidence backed psychedelic therapies for Addiction in clinics in the UK and Europe and through licencing partnerships globally.
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as “forward-looking statements”). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company’s future performance. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved, including statements relating to the proposed NEO listing, and the business of the Company. All forward-looking statements, including those herein are qualified by this cautionary statement.
Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information. These include: whether conditions to the listing on NEO will be satisfied; the business plans and strategies of the Company, the ability of the Company to comply with all applicable governmental regulations in a highly regulated business; the inherent risks in investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal in some jurisdictions; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; inconsistent public opinion and perception regarding the medical-use of psychedelic drugs; and regulatory or political change. Readers are cautioned that the foregoing list of factors is not exhaustive of the factors that may affect forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release speak only as of the date of this news release or as of the date or dates specified in such statements.
Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking information. For more information on the Company, investors are encouraged to review the Company’s public filings on SEDAR at www.sedar.com. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States. The Company’s and Awakn’s securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Investor Enquiries: KCSA Strategic Communications Valter Pinto / Tim Regan Phone: +1 (212) 896-1254 [email protected]
Media Enquiries: America and Canada: KCSA Strategic Communications Anne Donohoe [email protected]
Rest of World: ROAD Communications Paul Jarman / Anna Ramsey [email protected]
Posted by AGORACOM-JC
at 12:14 PM on Wednesday, June 23rd, 2021
To understand Awakn you first have to understand that …. Psychedelics are going to go through a parabolic, paradigm shifting growth in the next 5 years because of their ability to treat anxiety, depression and addiction … amongst other things Awakn Life Sciences is a biotechnology company with clinical operations developing, and delivering psychedelic medicine to better treat Addiction.
Awakn has a dual strategic focus:
Development: Research & developing the next generation of psychedelic drugs, therapies, and enabling technologies to better treat Addiction.
Delivery: Awakn will deliver evidence backed psychedelic therapies for Addiction in clinics in the UK and Europe and through licensing partnerships globally.
Notable Highlights include:
Strategic focus on better treating Addiction with psychedelics.
World leading team focused on psychedelic drug and therapy research.
Strong drug and therapy development pipeline, specifically targeting Addiction.
Clinics, which will be the UK and EU’s leading medical psychedelic therapy delivery
Closed $8.3M June 8
BRAND NEW LISTING … commencing trading on NEO
Sit back, relax and watch this powerful interview with CEO Anthony Tennyson.
Posted by AGORACOM-JC
at 11:38 AM on Tuesday, December 15th, 2020
Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.
3 Fully Operating Divisions For Investor Diversification
Innocan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.
Global Manufacturing / Distribution Agreements
Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
iAmHealth Distribution UG (Distribution – Germany)
Completed Trademark Registration in the EU, UK and Switzerland
Completion of the registration of its trademarks: Innocan Pharma, Relief & Go and SHIR in the EU, UK and Switzerland.
These trademarks represent Innocan’s OTC and derma cosmetic brand products that were recently launched in the German and UK markets.
Superior Management Team
In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself. The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:
Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
Together they have built one of the most formidable teams in the small cap cannabis world
